Stone House Investment Management »

Aurinia Pharmaceuticals shares owned by Stone House Investment Management

Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by Stone House Investment Management from 13F filings

Historical chart of Stone House Investment Management investment in Aurinia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aurinia Pharmaceuticals held by Stone House Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aurinia Pharmaceuticals by Stone House Investment Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $98k 6.6k 14.82

More positions owned by Stone House Investment Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Univrsl Usd (IUSB)
Ishares Tr S&p 500 Val Etf (IVE)
Ishares Tr S&p 500 Grwt Etf (IVW)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Ishares Core Msci Emkt (IEMG)
Procter & Gamble Company (PG)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr 10-20 Yr Trs Etf (TLH)
Ishares Tr Eafe Grwth Etf (EFG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Fidelity Covington Trust Enhanced Intl (FENI)
Blackrock Etf Trust Ishares A I Inno (BAI)
Ishares Tr Msci Usa Mmentm (MTUM)

View all positions for Stone House Investment Management

Top funds holding Aurinia Pharmaceuticals

Tang Capital Management
BlackRock
NEA Management Company
Two Sigma Investments
Arrowstreet Capital, Limited Partnership
State Street Corporation
Morgan Stanley
Renaissance Technologies
Marshall Wace
D. E. Shaw & Co
Geode Capital Management
Vanguard Group
Goldman Sachs Group
Vanguard Portfolio Management
Jacobs Levy Equity Management

View all funds holding Aurinia Pharmaceuticals